Prescient Therapeutics (ASX:PTX) - Webinar Presentation Company Presentations by Finance News Network August 15, 2022 03:46 PM Email Alerts for: ASX:PTX Steven Yatomi-Clarke – CEO & MD – Prescient Therapeutics (ASX:PTX) is focused on developing novel, personalised therapies for a range of cancers.
